BioCT welcomes new member New Haven Promise
New Haven Promise builds a college-going, career, and civic-launch culture throughout the city of New Haven in which students in the public schools aspire to attend...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
New Haven Promise builds a college-going, career, and civic-launch culture throughout the city of New Haven in which students in the public schools aspire to attend...
Alexion, AstraZeneca’s Rare Disease group, plans to expand its presence in New Haven with space at the new bioscience tower currently under construction at 101...
The FDA has approved a drug from New Haven-based BioXcel Therapeutics for the treatment of agitation associated with schizophrenia or bipolar disorder in adults. The FDA ruled that...
View this email in your browser Weekly Roundup – April 14, 2022 Yale recently announced a new innovations initiative: Yale Ventures. The initiative aims to...
Launc[H]artford, a business and entrepreneur support group, is partnering with Plug and Play Health to bring five startups to Hartford to evolve and grow their...
View this email in your browser Career News – April 12, 2022 BioCT Member Engagement Manager The John B. Pierce Laboratory Electronics/Computer Technician (JB03) Oova Content...
Thetis Pharmaceuticals has secured $4.2 million in non-dilutive financing from The Leona M. and Harry B. Helmsley Charitable Trust. Structured as a program-related investment in...
Cara Therapeutics says that biomarker data from the KALM-1 and KALM-2 clinical trials evaluating KORSUVA™ (difelikefalin) injection for the treatment of chronic kidney disease-associated pruritus in patients...
Rallybio has appointed Christine Nash, MBA and Hui Liu, Ph.D. to its Board of Directors. “Christine’s commercial and product launch experience in rare diseases and Hui’s industry...
View this email in your browser Weekly Roundup – April 7, 2022 Cybrexa Therapeutics co-founder Dr. Ranjit Bindra talks about the story behind his success in the latest...